相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study
Christof Rottenburger et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Cholecystokinin-2 Receptor Targeting with Radiolabeled Peptides: Current Status and Future Directions
Maximilian Klingler et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Initial In Vitro and In Vivo Evaluation of a Novel CCK2R Targeting Peptide Analog Labeled with Lutetium-177
Anton Amadeus Hoermann et al.
MOLECULES (2020)
Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [177Lu]Lu-PP-F11N
Michal Grzmil et al.
THERANOSTICS (2020)
Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog 177Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?
Alexander W. Sauter et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples
Petra Kolenc Peitl et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2019)
DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use
Maximilian Klingler et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting
Maximilian Klingler et al.
THERANOSTICS (2018)
A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study
Paola A. Erba et al.
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2018)
European regulations for the introduction of novel radiopharmaceuticals in the clinical setting
Clemens Decristoforo et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Medullary thyroid carcinoma - PET/CT imaging with 68Ga-labelled gastrin and somatostatin analogues
Jolanta Kunikowska et al.
ENDOKRYNOLOGIA POLSKA (2016)
Biodistribution and radiation dosimetry of 68Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer
Christian H. Pfob et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Stereochemistry of Amino Acid Spacers Determines the Pharmacokinetics of 111In DOTA Minigastrin Analogues for Targeting the CCK2/Gastrin Receptor
Petra Kolenc Peitl et al.
BIOCONJUGATE CHEMISTRY (2015)
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)
Sergio Todde et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount
Mark W. Konijnenberg et al.
EJNMMI RESEARCH (2014)
Clinical applications of Gallium-68
Sangeeta Ray Banerjee et al.
APPLIED RADIATION AND ISOTOPES (2013)
Comparative Biodistribution and Radiation Dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in Patients with Neuroendocrine Tumors
Mattias Sandstrom et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Characterization of a novel five-transmembrane domain cholecystokinin-2 receptor splice variant identified in human tumors
Claire Sanchez et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
In Vitro and In Vivo Characterization of Three 68Ga- and 111In-Labeled Peptides for Cholecystokinin Receptor Imaging
Susan Roosenburg et al.
MOLECULAR IMAGING (2012)
Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides
Peter Laverman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Highly Improved Metabolic Stability and Pharmacokinetics of Indium-111-DOTA-Gastrin Conjugates for Targeting of the Gastrin Receptor
Petra Kclenc-Peitl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Normal tissue tolerance to external beam radiation therapy: The stomach
P. Oberdiac et al.
CANCER RADIOTHERAPIE (2010)
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
Dik J. Kwekkeboom et al.
ENDOCRINE-RELATED CANCER (2010)
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
Irene Virgolini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
A fully automated synthesis for the preparation of 68Ga-labelled peptides
Clemens Decristoforo et al.
NUCLEAR MEDICINE COMMUNICATIONS (2007)
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT
Michael Gabriel et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Peptide receptors as molecular targets for cancer diagnosis and therapy
JC Reubi
ENDOCRINE REVIEWS (2003)
Comparison of internal radiation doses estimated by MIRD and voxel techniques for a family of phantoms
T Smith et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
分享论文
